Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Cerebrospinal Fluid BAFF and APRIL Levels in Neuromyelitis Optica and Multiple Sclerosis Patients During Relapse.
Development of nucleic acid drugs for neurological disorders.
Sexual Behavior, Body Image, and Partnership in Chronic Illness: A Comparison of Huntington's Disease and Multiple Sclerosis.
β-Lapachone ameliorization of experimental autoimmune encephalomyelitis.
Inhibition of Calcineurin Abrogates While Inhibition of mTOR Promotes Regulatory T Cell Expansion and Graft-Versus-Host Disease Protection by IL-2 in Allogeneic Bone Marrow Transplantation.
Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients.
Can a Low-Cost Webcam be Used for a Remote Neurological Exam?
The Diagnostic Accuracy of Static Posturography in Predicting Accidental Falls in People With Multiple Sclerosis.
[Budget impact analysis of the first-line treatment of relapsing remitting multiple sclerosis in Spain].
Modifiable Comorbidities and Disability in Multiple Sclerosis.
A population based cohort study to assess the safety of pandemic influenza vaccine Focetria(®) in Emilia-Romagna region, Italy-Part Two.
Quetiapine, an Atypical Antipsychotic, Is Protective against Autoimmune-Mediated Demyelination by Inhibiting Effector T Cell Proliferation.
Anesthetic management of a parturient with neuromyelitis optica.
Spasticity: pathophysiology, evaluation and management.
Combined oral contraceptives: health benefits beyond contraception.
Teva and Active Biotech Announce Expansion of Laquinimod Clinical Development Program with New Trial in Primary Progressive Multiple Sclerosis and First Patient Screened in Huntington's Disease Trial
Role of the innate and adaptive immune responses in the course of multiple sclerosis.
Age-specific sex ratio of multiple sclerosis in the National Swedish MS Register (SMSreg).
A consensus statement addressing mesenchymal stem cell transplantation for multiple sclerosis: it's time!
Increased B cell and cytotoxic NK cell proportions and increased T cell responsiveness in blood of natalizumab-treated multiple sclerosis patients.
Insights into the Mechanisms of the Therapeutic Efficacy of Alemtuzumab in Multiple Sclerosis.
Natalizumab adverse events are rare in patients with multiple sclerosis.
Animal assisted interventions in neurorehabilitation: A review of the most recent literature.
A hypermorphic SP1-binding CD24 variant associates with risk and progression of multiple sclerosis.
Effects of non-steroidal antiinflammatory drugs on D-serine-induced oxidative stress in vitro.

Pages